Cargando…
Prostate Cancer – To screen, or not to screen, is that the question?
There continues to be controversy regarding serum Prostate-Specific Antigen (PSA) and prostate cancer screening. We anxiously await the results of two large prospective randomized clinical trials (Prostate, Lung, Colon, and Ovary-PCLO screening trial in the US and European Randomized Study of Screen...
Autor principal: | Rosser, Charles J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630990/ https://www.ncbi.nlm.nih.gov/pubmed/19105847 http://dx.doi.org/10.1186/1471-2490-8-20 |
Ejemplares similares
-
Gestational Diabetes Mellitus: To Screen or Not to Screen?: Is this really still a question?
por: Simmons, David, et al.
Publicado: (2013) -
Is the practice of colorectal cancer screening questionable after the NordICC trial was published?
por: Wong, Martin C. S., et al.
Publicado: (2023) -
Ethnicity and prostate cancer: the way to solve the screening problem?
por: Bokhorst, Leonard P., et al.
Publicado: (2015) -
Discoveries and application of prostate-specific antigen, and some proposals to optimize prostate cancer screening
por: Tokudome, Shinkan, et al.
Publicado: (2016) -
Familial Pancreatic Cancer: To Screen or not to Screen?
por: Vasen, Hans F.A., et al.
Publicado: (2015)